Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
15,851,374
-
Shares change
-
+112,652
-
Total reported value, excl. options
-
$230,319,696
-
Value change
-
-$10,049,412
-
Put/Call ratio
-
170%
-
Number of buys
-
49
-
Number of sells
-
-35
-
Price
-
$14.53
Significant Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q3 2015
99 filings reported holding BLCM - BELLICUM PHARMACEUTICALS INC - COM as of Q3 2015.
BELLICUM PHARMACEUTICALS INC - COM (BLCM) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15,851,374 shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (4,190,594 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,416,386 shares), JPMORGAN CHASE & CO (1,191,668 shares), FMR LLC (1,000,000 shares), MILLENNIUM MANAGEMENT LLC (992,616 shares), FRANKLIN RESOURCES INC (713,500 shares), CITADEL ADVISORS LLC (620,225 shares), VANGUARD GROUP INC (589,115 shares), PERCEPTIVE ADVISORS LLC (521,188 shares), and MORGAN STANLEY (352,407 shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.